Literature DB >> 15711503

Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?

O Mayzler1, N Weksler, S Domchik, M Klein, S Mizrahi, G M Gurman.   

Abstract

AIM: An association has been proposed between perioperative administration of 80% oxygen and a lower incidence of wound infection after colorectal surgery. The present study was conducted to assess this hypothesis.
METHODS: Thirty-eight patients (ASA classification 1 and 2) undergoing elective colorectal cancer surgery were allocated at random to 2 groups. Group 1 consisted of 19 patients who received an admixture of 80% oxygen and 20% nitrogen during anesthesia through an orotracheal tube and during the 2 first hours in the recovery room through a tight facemask with reservoir. Group 2 consisted of 19 patients who received an admixture of 70% nitrous oxide and 30% oxygen during anesthesia, followed by administration of 30% oxygen delivered by a blender through a tight facemask with reservoir in the same manner than group 1, during the first 2 hours in the recovery room. Wound infection was evaluated daily during hospital stay and after 7 days, 2 weeks, and 1 month.
RESULTS: The incidence of wound infection was 12.5% in group 1 and 17.6% in group 2 (p=0.53).
CONCLUSIONS: The results of this study showed no reduction in the incidence of wound infection following elective colorectal surgery in patients receiving 80% oxygen during the perioperative period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711503

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  22 in total

Review 1.  Optimizing perioperative care in bariatric surgery patients.

Authors:  Daniel P Lemanu; Sanket Srinivasa; Primal P Singh; Sharon Johannsen; Andrew D MacCormick; Andrew G Hill
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

Review 2.  High inspired oxygen versus low inspired oxygen for reducing surgical site infection: a meta-analysis.

Authors:  Hongye Wang; Shukun Hong; Yuanyuan Liu; Yan Duan; Hongmei Yin
Journal:  Int Wound J       Date:  2015-12-23       Impact factor: 3.315

Review 3.  High-concentration oxygen and surgical site infections in abdominal surgery: a meta-analysis.

Authors:  Sunil V Patel; Shaun C Coughlin; Richard A Malthaner
Journal:  Can J Surg       Date:  2013-08       Impact factor: 2.089

4.  CAGS and ACS evidence based reviews in surgery. 36. Effect of high perioperative oxygen fraction on surgical site infection.

Authors:  Andrew W Kirkpatrick; Giuseppe Papia; Stuart A McCloskey; Hiram C Polk; Ozan Akca; Motaz Qadan
Journal:  Can J Surg       Date:  2011-02       Impact factor: 2.089

5.  The WHO recommendation for 80% perioperative oxygen is poorly justified.

Authors:  T Volk; J Peters; D I Sessler
Journal:  Anaesthesist       Date:  2017-04       Impact factor: 1.041

6.  Generating evidence for surgical practice in Africa: the role of clinical research.

Authors:  Jonah Musa
Journal:  Afr J Paediatr Surg       Date:  2012 Jan-Apr

Review 7.  Infection control in colon surgery.

Authors:  Donald E Fry
Journal:  Langenbecks Arch Surg       Date:  2016-06-27       Impact factor: 3.445

Review 8.  Perioperative hyperoxia: perhaps a malady in disguise.

Authors:  Yalim Dikmen; Aybike Onur
Journal:  Rom J Anaesth Intensive Care       Date:  2017-04

Review 9.  Hyperoxia: a review of the risks and benefits in adult cardiac surgery.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2012-12

10.  Perioperative oxygen fraction - effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial.

Authors:  Christian S Meyhoff; Jørn Wetterslev; Lars N Jorgensen; Steen W Henneberg; Inger Simonsen; Therese Pulawska; Line R Walker; Nina Skovgaard; Kim Heltø; Peter Gocht-Jensen; Palle S Carlsson; Henrik Rask; Sharaf Karim; Charlotte G Carlsen; Frank S Jensen; Lars S Rasmussen
Journal:  Trials       Date:  2008-10-22       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.